Summary by Moomoo AI
On June 4, 2024, Keji Pharmaceutical Holdings Co., Ltd. (Keji Pharmaceutical-B) submitted its disclosure report for the next day, disclosing its share repurchase. According to the report, the company repurchased 400,000 and 60,500 ordinary shares respectively on May 31 and June 4, 2024, but did not cancel them. After the repurchase, the company's issued share capital remained at 575,653,415 shares. The repurchase transaction on June 4 was conducted at a maximum price of HK$7 per share and a minimum price of HK$6.7 per share, with a total cost of HK$423,055.01. So far this year, the company has repurchased a total of 460,500 shares on the Hong Kong Stock Exchange, accounting for 0.08% of the issued shares. The company confirmed that all transactions were conducted in accordance with the rules of the Hong Kong Stock Exchange and there were no significant changes.